Brogdon
Brian N. Brogdon, Marietta, GA US
Patent application number | Description | Published |
---|---|---|
20110174454 | PAPERMAKING METHOD USING ONE OR MORE QUATERNIZED DIALKANOLAMINE FATTY ACID ESTER COMPOUNDS TO CONTROL OPACITY AND PAPER PRODUCT MADE THEREBY - A method for making an opacity relevant grade paper or paperboard product, such as a communication type paper used for printing and writing applications, utilizes an effective amount of quaternized alkanolamine fatty acid ester compounds as an opacification aid to control the optical properties of the paper or paperboard product as a wet-end additive to a papermaking operation. Using the quaternized alkanolamine fatty acid ester compound can improve the opacity of the paper or paperboard product, maintain the opacity of the paper while reducing the use of other opacification aids, such as inorganic fillers and/or pigments, and allow for a reduction in paper grammage without a compromise in opacity. The improvements in paper optical properties are achieved without adversely affecting other characteristics of the paper product such as bulk value, tensile strength, tear index, and the like. | 07-21-2011 |
Gregory Ralph Brogdon, Gardena, CA US
Patent application number | Description | Published |
---|---|---|
20100096872 | CARGO SYSTEM FOR CARGO AREA OF VEHICLE - A cargo system for use within the cargo area of a vehicle. The cargo system has an elongated crossbar and at least two brackets for supporting the crossbar while it spans the cargo area. The brackets may adapt a roof top storage rack for use in the cargo area or bed of a truck. The brackets may engage standard truck bed components such as D-rings, deck rails, and cleats to secure the cargo system. The cargo system may be positioned anywhere in the cargo area depending upon the positions, i.e., sidewall or bottom, of the supports for the brackets. | 04-22-2010 |
James W. Brogdon, Daphne, AL US
Patent application number | Description | Published |
---|---|---|
20090101123 | MULTIPLE HEIGHT FLUID MIXER AND METHOD OF USE - A mixer assembly ( | 04-23-2009 |
Jennifer Brogdon, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20140271635 | TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR - The invention provides compositions and methods for treating diseases associated with expression of CD19. The invention also relates to chimeric antigen receptor (CAR) specific to CD19, vectors encoding the same, and recombinant T cells comprising the CD19 CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a CD19 binding domain. | 09-18-2014 |
20140322212 | EFFECTIVE TARGETING OF PRIMARY HUMAN LEUKEMIA USING ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR ENGINEERED T CELLS - The invention provides compositions and methods for treating leukemia, for example, acute myeloid leukemia (AML) and B-cell acute lymphoid leukemia (B-ALL). The invention also relates to at least one chimeric antigen receptor (CAR) specific to CD123, vectors comprising the same, and recombinant T cells comprising the CD123 CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a CD123 binding domain. The invention also includes methods of bone marrow ablation for use in treatments necessitating bone marrow reconditioning or transplant. | 10-30-2014 |
20140322275 | TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR - The invention provides compositions and methods for treating diseases associated with expression of EGFRvIII. The invention also relates to chimeric antigen receptor (CAR) specific to EGFRvIII, vectors encoding the same, and recombinant T cells comprising the anti-EGFRvIII CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an anti-EGFRvIII binding domain. | 10-30-2014 |
Jennifer Brogdon, Sudbury, MA US
Patent application number | Description | Published |
---|---|---|
20140377281 | LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE - The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same. | 12-25-2014 |
Shawn Michael Brogdon, Marietta, GA US
Patent application number | Description | Published |
---|---|---|
20120105248 | Physiological Data Acquisition and Management System for Use with an Implanted Wireless Sensor - Aspects and embodiments of the present invention provide a system for obtaining, processing and managing data from an implanted sensor. In some embodiments, a patient or other persons can use a flexible antenna to obtain data from the implanted sensor. The flexible antenna includes at least one transmit loop and at least one receive loop. The transmit loop is adapted to propagate energizing signals to the implanted sensor. The receive loop is adapted to detect a response signal from the implanted sensor. The transmit loop includes a capacitor formed by a discontinuous area. The capacitor is adapted to allow the loop to be tuned. The flexible antenna can communicate with a patient device that collects the data from the implanted sensor, creates a data file and transmits the data file to a remote server over a network. A physician or other authorized person may access the remote server using an access device. | 05-03-2012 |